Saturday, October 20, 2018
Home Eric Rosenthal Reports

Eric Rosenthal Reports

In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose millions of dollars in payments from industry, I reached out to learn a little bit...
This year marks the 10th anniversary of the launch of Stand Up To Cancer (SU2C)—an enterprise that was at its inception an innovative and somewhat radical concept in cancer research: creating collaborative dream teams of researchers from various disciplines...
During last year’s American Association for Cancer Research (AACR) annual meeting in Washington, DC, the association’s president Michael A. Caligiuri, MD, discussed his presidential initiative to further cancer health equality. He said this would include: reducing health disparities; recruiting, retaining,...
Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion. Roche already held a 12% stake in Flatiron, so the total value of the deal--which was...
James F. Holland, MD, one of the pioneers of combination chemotherapy and cancer cooperative group research, died at the age of 92 on March 22. His wife, Jimmie C. Holland, MD, who was considered the founder of psycho-oncology, predeceased...

Related articles